Search Results 1581-1590 of 3926 for Solid
Coagulation defects; Hematological disorders associated with solid organ transplantation. Mayo Clinic locations · Phx. Phoenix, Arizona. Driving directions ...
* Prior solid organ (heart, liver, kidney, lung) transplant or hematopoietic cell transplant. Note: Other protocol defined Inclusion/Exclusion Criteria may ...
- Prior allogeneic stem cell or solid organ transplant - Treatment with systemic immunostimulatory agents within 4 weeks prior to initiation of study ...
Measurable disease is defined by Response Evaluation Criteria in Solid Tumors (RECIST) (version 1.1); measurable disease is defined as at least one lesion ...
At least one measurable lesion according to Response Evaluation Criteria in Solid Tumors (RECIST) 1.1. Eastern Cooperative Oncology Group (ECOG) performance ...
History of allogeneic bone marrow, stem cell, or solid organ transplant; Treatment with systemic cancer therapy or investigational therapy within 4 weeks of ...
... solid tumors. It is necessary that ctDNA test results are linked to clinical outcomes in order to demonstrate clinical validity for recurrence detection and ...
Sawyer MD, Mayoral JL, Gillingham KJ, Kramer MA, Dunn DL. Treatment of recurrent cytomegalovirus disease in patients receiving solid organ transplants. Arch ...
Together, they deliver hope and individualized care for children with solid tumors that require surgery, including neuroblastoma, liver tumors, kidney tumors ...
Measurable or non-measurable disease (but radiologically evaluable) according to Response Evaluation Criteria in Solid Tumors (RECIST) v1.1 criteria.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.